NOV Enterprise Value Over E B I T D A from 2010 to 2025

NOV Stock  USD 14.47  0.07  0.49%   
NOV Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2025. During the period from 2010 to 2025, NOV Enterprise Value Over EBITDA regression line of quarterly data had r-squared of  0 and coefficient of variation of  121.80. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
10.94
Current Value
15.04
Quarterly Volatility
16.86390413
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NOV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NOV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 369.1 M, Interest Expense of 46.8 M or Total Revenue of 8.8 B, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.015 or PTB Ratio of 2.1. NOV financial statements analysis is a perfect complement when working with NOV Valuation or Volatility modules.
  
Check out the analysis of NOV Correlation against competitors.

Latest NOV's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of NOV Inc over the last few years. It is NOV's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NOV's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Very volatile
   Enterprise Value Over E B I T D A   
       Timeline  

NOV Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean13.85
Coefficient Of Variation121.80
Mean Deviation11.69
Median10.94
Standard Deviation16.86
Sample Variance284.39
Range65.4241
R-Value0.06
Mean Square Error303.59
R-Squared0
Significance0.82
Slope0.21
Total Sum of Squares4,266

NOV Enterprise Value Over E B I T D A History

2025 15.04
2024 10.94
2023 9.51
2022 15.31
2021 39.39
2020 -2.62
2019 -1.92

About NOV Financial Statements

NOV investors use historical fundamental indicators, such as NOV's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NOV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 10.94  15.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NOV Stock Analysis

When running NOV's price analysis, check to measure NOV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOV is operating at the current time. Most of NOV's value examination focuses on studying past and present price action to predict the probability of NOV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOV's price. Additionally, you may evaluate how the addition of NOV to your portfolios can decrease your overall portfolio volatility.